Compare AIR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIR | TMDX |
|---|---|---|
| Founded | 1951 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.6B |
| IPO Year | 1994 | 2019 |
| Metric | AIR | TMDX |
|---|---|---|
| Price | $107.34 | $99.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $128.80 | ★ $154.00 |
| AVG Volume (30 Days) | 454.1K | ★ 923.9K |
| Earning Date | 03-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 3.59 | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $16.67 | $24.51 |
| Revenue Next Year | $10.51 | $18.73 |
| P/E Ratio | $30.91 | ★ $20.97 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $46.51 | $62.42 |
| 52 Week High | $122.97 | $156.00 |
| Indicator | AIR | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 24.72 |
| Support Level | $72.99 | N/A |
| Resistance Level | $119.82 | $131.86 |
| Average True Range (ATR) | 4.87 | 5.48 |
| MACD | 0.15 | -2.58 |
| Stochastic Oscillator | 34.57 | 3.82 |
AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.